Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations – A message for Central and Eastern Europe-Reference-Cited by-同舟云学术

Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations – A message for Central and Eastern Europe

Published:2017-11-13 Issue:11 Volume:12 Page:e0186131
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kowalska Justyna D.^ORCID,Wójcik Grzegorz,Rutkowski Jakub,Ankiersztejn-Bartczak Magdalena,Siewaszewicz Ewa

Funder

Gilead Science (PL)

Gilead Sciences (PL)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy;JD Kowalska;Aids,2012

2. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group;A Mocroft;Lancet,1998

3. Cost-effectiveness of antiretroviral therapy for prevention;JG Kahn;Curr HIV Res,2011

4. Global AIDS Update 2016. UNAIDS. Available at: http://www.unaids.org/en/resources/documents/2016/Global-AIDS-update-2016.

5. Prevention of HIV-1 infection with early antiretroviral therapy;MS Cohen;N Engl J Med,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid antiretroviral treatment start seems as vital and cost-effective strategy in Central and Eastern Europe;Przeglad Epidemiologiczny;2022-12-01

2. Impact and cost-effectiveness of non-governmental organizations on the HIV epidemic in Ukraine among MSM;AIDS;2022-08-10

3. Injecting drug users, MSM and people at the older age should be routinely tested for HCV in Poland – data derived from a post-exposure prophylaxis population;Annals of Agricultural and Environmental Medicine;2021-12-29

4. Is age and not antiretroviral therapy the strongest risk factor for chronic pain in HIV-infected population?;BMC Infectious Diseases;2021-02-01

5. People who inject drugs remain hard-to-reach population across all HIV continuum stages in Central, Eastern and South Eastern Europe – data from Euro-guidelines in Central and Eastern Europe Network;Infectious Diseases;2019-02-21